open access

Vol 52, No 1 (2021)
Short communication
Submitted: 2021-02-08
Accepted: 2021-02-08
Get Citation

Intravascular lung coagulopathy by COVID-19

Laura Montero Martín, Begoña Fernández-Jiménez
DOI: 10.5603/AHP.2021.0010
·
Acta Haematol Pol 2021;52(1):68-71.

open access

Vol 52, No 1 (2021)
SHORT COMMUNICATION
Submitted: 2021-02-08
Accepted: 2021-02-08

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Intravascular lung coagulopathy by COVID-19

Journal

Acta Haematologica Polonica

Issue

Vol 52, No 1 (2021)

Article type

Short communication

Pages

68-71

DOI

10.5603/AHP.2021.0010

Bibliographic record

Acta Haematol Pol 2021;52(1):68-71.

Authors

Laura Montero Martín
Begoña Fernández-Jiménez

References (12)
  1. Hunt B, Retter A, McClintock C. Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19. https://thrombosisuk.org/covid-19-thrombosis.php (April 9, 2020).
  2. Guan WJ, Ni Zy, Hu Yu, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708–1720.
  3. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (March 11, 2020).
  4. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497–506.
  5. Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844–847.
  6. Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost. 2020; 18(4): 786–787.
  7. Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017; 149: 38–44.
  8. Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18(5): 1094–1099.
  9. McGonagle D, O'Donnell J, Sharif K, et al. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020; 2(7): e437–e445.
  10. Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. The Lancet. 2020; 395(10235): 1517–1520.
  11. Yan SF, Mackman N, Kisiel W, et al. Hypoxia/Hypoxemia-Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis. Arterioscler Thromb Vasc Biol. 1999; 19(9): 2029–2035.
  12. Thachil J. The versatile heparin in COVID-19. J Thromb Haemost. 2020; 18(5): 1020–1022.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl